Search For "zydus lifesciences ltd"
Pinkathon partners with Zydus to drive breast cancer awareness; Returns to
Updated : 5 months, 4 weeks ago IST
Hyderabad (Telangana) [India], December 11: Pinkathon, India's biggest women's run, today announced the 6th edition of Pinkathon Hyderabad, joining hands with global innovation-led healthcare company Zydus Lifesciences Ltd. to strengthen breast cancer awareness in India. The press conference
Read More
Pinkathon partners with Zydus to drive breast cancer awareness; Returns to
Updated : 6 months, 3 weeks ago IST
Bengaluru (Karnataka) [India], November 19: Pinkathon, India's biggest women's run, has joined hands with global innovation-led healthcare company Zydus Lifesciences Ltd. in a purpose-driven partnership to strengthen breast cancer awareness in India. The upcoming 8th edition of the Bengaluru
Read More
Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2
Updated : 8 months, 1 week ago IST
Pennington (New Jersey) [US] / Ahmedabad (Gujarat) [India], August 30: Zydus Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., a global innovation led healthcare company, today announced positive topline results from the pivotal EPICS-III Phase 2(b)/3 clinical trial. In
Read More
Zydus to Enter Global Biologics CDMO Business Plans to Acquire Agenus' U.S
Updated : 1 year ago IST
New Jersey [US]/ Ahmedabad (Gujarat) [India], June 3: Zydus Lifesciences Ltd. (including its subsidiaries/affiliates, hereafter referred to as "Zydus) today announced its entry into the global biologics contract development and manufacturing organization (CDMO) business through its plan to a
Read More
25 Years of Listing on NSE - Zydus Lifesciences Limited
Updated : 1 year, 1 month ago IST
Mumbai (Maharashtra) [India], May 3: To commemorate the 25th year of the listing of Zydus Lifesciences Ltd. (formerly known as Cadila Healthcare Ltd.) on the National Stock Exchange of India (NSE), a bell ringing ceremony was organized at BKC, Mumbai on 2nd May 2025. On this occasion, senior
Read More
Zydus Lifesciences Launches Rexigo, the Oral Once-a-Day Pill for Advanced
Updated : 2 years, 4 months ago IST
Ahmedabad (Gujarat) [India], January 30: Zydus Lifesciences Ltd., a global innovation-driven healthcare company announced that it has launched Relugolix under the brand name, Rexigo™. This is the first and only oral once-a-day therapy for testosterone suppression in patients with advan
Read More
Zydus Lifesciences Q2 Net Profit up by 53% Y-o-Y
Updated : 2 years, 7 months ago IST
Ahmedabad (Gujarat) [India], November 7: Zydus Lifesciences Ltd. announced its unaudited consolidated financial results for the quarter and half year ended September 30th, 2023.
Read More
Experts at the 4th Edition of Rabies Awareness Summit Stress on Community
Updated : 2 years, 8 months ago IST
New Delhi [India], October 9: Public health experts at the 4th Edition of Rabies Awareness Summit agreed that sensitisation through digital means coupled with track and treat approach can play significant role in achieving the target of a "Rabies Free India by 2030". The Summit was organised
Read More
DCGI grants EUA to ZycovD COVID vaccine for two-dose regimen for children
Updated : 4 years, 1 month ago IST
Ahmedabad (Gujarat) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Zydus Cadila vaccine (ZycovD) for COVID-19 as a two-dose vaccine for children above the age of 12 years, said Zydus Lifesciences Ltd., the phar
Read More
Zydus receives final approval from USFDA to market Colestipol Hydrochlorid
Updated : 4 years, 2 months ago IST
Ahmedabad (Gujarat) [India], March 15 (ANI): Zydus Lifesciences Ltd. has received final approval from the United States Food and Drug Administration (USFDA) to market Colestipol Hydrochloride Tablets in the strength of 1mg (US RLD: Colestid), said the pharmaceutical company on Monday.
Read More
Zydus receives final approval from USFDA to market drug used to relieve ch
Updated : 4 years, 3 months ago IST
New Delhi [India], March 9 (ANI): Zydus Lifesciences Ltd. has received final approval from the United States Food and Drug Administration (USFDA) to market Nitroglycerin Sublingual tablets used to relieve chest pain in people who have certain heart conditions, said the pharmaceutical company
Read More